Addictions, Drug & Alcohol Institute (ADAI) at the University of Washington

Name

Addictions, Drug & Alcohol Institute (ADAI) at the University of Washington

Legal name

Addictions, Drug & Alcohol Institute (ADAI), University of Washington

Website

https://adai.uw.edu

Company type

Private

Founded year

1973

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

Addiction Research and Public Health Services

NAICS

Outpatient Mental Health and Substance Abuse Centers (621420), Individual and Family Services (6241)

SIC

Services-Health Services (8000), Services-Social Services (8300)

akta.pro industry

PRIMARYHLAFACAG

Medication-Assisted Treatment (MAT) & Opioid Treatment Programs (OTPs)

Healthcare & Life Sciences/Healthcare Providers & Systems/Behavioral Health & Substance Use Treatment

SECONDARYBPAGAEAO

Substance Use Recovery & Harm Reduction Support Services

Business & Public Services/Nonprofit, NGO & Social Services/Social Services & Community Support (Food, Housing, Family)

SECONDARYHLAJAAAM

Substance Use, Addiction & Harm Reduction Health Departments

Healthcare & Life Sciences/Public Health, Government & Regulators/Public Health Agencies & Health Departments

SECONDARYBPAIAJAK

Behavioral Health & Substance Use Public Health Programs

Business & Public Services/Public Sector & Government Administration/Public Health Administration & Regulation

Keywords

• Addiction research services
• Substance use disorder training
• Harm reduction programs
• Clinical trials consulting
• Workforce continuing education

Headquarters

HQ city

Seattle

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Others, Marketing or Sales

Revenue model

1. Grant Funding: ADAI is a university research institute funded primarily through government grants from NIH, NIDA, SAMHSA, and state agencies including the Washington State Health Care Authority and Department of Health. The institute also receives support through the NIDA Clinical Trials Network and operates as part of the ATTC (Addiction Technology Transfer Center) network.
2. Small Grants Program: ADAI awards small grants ($30,000 to faculty, $20,000 to students/postdocs) to UW researchers for pilot studies in alcohol and drug use research. This stimulates and facilitates addiction research at the university.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels10 records

Core offering

ADAI operates as a multi-program addiction research, training, and public-health service institute within the University of Washington. It delivers applied research, implementation support, clinical-trial consultation, harm-reduction services, and continuing-education training to healthcare organizations, government agencies, first responders, and the addiction treatment workforce across Washington State and the Pacific Northwest. Core outputs include the Clinical Trials Network Pacific Northwest Node, the Community Drug Checking Network, the Northwest ATTC training program, the Parent-Child Assistance Program, and free public resources such as StopOverdose.org and the Interactive Opioid Data platform.

Product overview

ADAI is a university research institute at the University of Washington operating as a multi-program organization focused on addiction science, research, education, and training. The institute comprises distinct centers and programs including: the Center for Community-Engaged Drug Education, Epidemiology & Research (CEDEER) for community-based drug research; the Cannabis Education & Research Program (CERP) for cannabis-specific research; the Center for Novel Therapeutics in Addiction Psychiatry (NTAP) for psychedelic-assisted treatment research; the Center for Advancing Addiction Health Services (CAAHS) for implementation science; the Fetal Alcohol & Drug Unit (FADU) for prenatal exposure research; and the Clinical Trials Network Pacific Northwest Node for clinical trials. ADAI also operates training programs including the Northwest ATTC, Summer Internship Program, and Lunch & Learn Webinar Series. Key resources include the Washington State Interactive Drug Data platform, Community Drug Checking Network (CDCN), Health Engagement Programs with Implementation Resource Kit, Empathy Lens Image Collection, StopOverdose.org, and LearnAboutTreatment.org. The Small Grants Program provides funding to UW researchers. The institute does not offer a unified software product but rather serves as a research and training hub with multiple educational platforms, data tools, and community service programs.

Differentiator

Problem solved

Functional benefit

Brands

• Center for Advancing Addiction Health Services (CAAHS): Accelerates adoption and implementation of addiction treatment and recovery practices
• Center for Community-Engaged Drug Education, Epidemiology & Research (CEDEER)
• Cannabis Education & Research Program (CERP)
• Center for Novel Therapeutics in Addiction Psychiatry (NTAP)
• Northwest ATTC
• Empathy Lens Collection
• StopOverdose.org
• LearnAboutTreatment.org

Products and services

• Center for Advancing Addiction Health Services (CAAHS) Implementation support program that helps healthcare organizations and treatment providers adopt evidence-based addiction treatment and recovery practices through training, technical assistance, and capacity building.
• Center for Community-Engaged Drug Education, Epidemiology & Research (CEDEER) Community-based drug education, epidemiology, and research program that supports the health of people who use drugs in Washington State through surveys with SSPs and harm reduction partners.
• Cannabis Education & Research Program (CERP) Research and education program dedicated to studying cannabis-related problems, adverse health outcomes, and clinical barriers to treatment intervention.
• Center for Novel Therapeutics in Addiction Psychiatry (NTAP) Research center creating new ways of treating alcohol, opioid, tobacco, and other addictions by combining psychedelic compounds with evidence-based behavioral interventions.
• Clinical Trials Consultation and Technical Assistance Program (C-TAP) Consultation service that helps investigators with clinical research design, implementation, and dissemination, providing coaching and hands-on support from expert PIs and project directors.
• Clinical Trials Network Pacific Northwest Node NIDA Clinical Trials Network node conducting multi-site clinical trials to test addiction treatments and disseminate evidence-based practices across the Pacific Northwest.
• Fetal Alcohol & Drug Unit (FADU) Research unit focused on fetal alcohol spectrum disorders and related drug research, including operation of the award-winning Parent-Child Assistance Program for mothers with substance use issues.
• Parent-Child Assistance Program (PCAP) Award-winning home visitation case-management model serving mothers with substance use issues, with proven effectiveness in supporting recovery and family stability.
• Ferguson Lab Research lab studying substance use disorders, maladaptive decision-making, and the neural mechanisms underlying addiction, including psychedelic treatment mechanisms.
• Northwest ATTC (Addiction Technology Transfer Center) Regional ATTC providing training, webinars, and continuing education for the addiction treatment workforce across the Pacific Northwest, with CME/CE credits available.
• ADAI Small Grants Program Intramural pilot research grants program awarding funds to UW researchers for pilot studies and developmental research on alcohol and drug use and addiction.
• Washington State Community Drug Checking Network (CDCN) Partnership-based community drug-checking service using FTIR spectroscopy, drug test strips, and mass spectrometry to identify substances in the unregulated drug supply across five Washington State sites.
• Health Engagement Programs Low-barrier substance use treatment, harm reduction, and basic medical services for people who use drugs, co-located with syringe services programs across Washington State.
• Implementation Resource Kit for Health Engagement Programs Comprehensive toolkit that helps community organizations plan, implement, and sustain health engagement programs, including implementation roadmap, sample protocols, policies, staffing documents, and training materials.
• Empathy Lens Image Collection Free photo resource providing realistic, respectful images of people who use drugs for use in education, media, and information outreach to reduce stigma.
• Washington State Interactive Opioid/Major Drug Data Interactive data platform with charts and maps featuring Washington State data on overdose deaths, treatment admissions, opioid sales, and other substance use indicators.
• ADAI Clearinghouse Online clearinghouse providing access to ADAI publications, reports, and educational materials on addiction and substance use disorder topics.
• CTN Dissemination Library Repository of NIDA Clinical Trials Network resources and research publications on addiction treatment.
• StopOverdose.org Public education website providing information and resources on overdose prevention and response for community members and professionals.
• LearnAboutTreatment.org Public education website providing professional tools and resources for learning about treatment approaches for substance use disorders.
• E-Learning and Interventions Suite of online educational modules and e-learning resources for self-paced training on addiction-related topics for professionals and students.
• ADAI Summer Internship Program Summer internship program for UW undergraduates interested in substance use, addictions, public health, and health communications.
• ADAI Lunch & Learn Webinar Series Monthly virtual webinar series providing education on addiction-related topics for professionals, students, and the public.

Quantifiable outcome

• At sites with smoking supplies, 35% of SSP participants reported injecting drugs vs 70% at sites without smoking supplies
• +3 more outcomes

Named customers6 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

16 partnerships are on record, tiered core and major.

• NIDA Clinical Trials Network - Pacific Northwest NodecoreStrategic or Co-development PartnerADAI houses the Pacific Northwest Node of the NIDA Clinical Trials Network, conducting clinical trials and research on addiction treatment. The node collaborates with other CTN nodes on joint webinars and research initiatives.
• Northwest Addiction Technology Transfer Center (Northwest ATTC)coreStrategic or Co-development PartnerThe Northwest ATTC is housed at ADAI and provides training and professional development for the addiction treatment workforce across the Northwest region, offering webinars and continuing education.
• Pacific Southwest ATTCcoreStrategic or Co-development PartnerJoint webinar sponsorship and collaboration with the Pacific Southwest ATTC on addiction treatment education and training programs.
• Western States Node of the NIDA CTNcoreStrategic or Co-development PartnerCollaboration on joint webinars and research initiatives related to addiction treatment and buprenorphine.
• Public Health-Seattle & King CountycoreStrategic or Co-development PartnerCollaboration on syringe services program surveys, drug checking network, and community health initiatives. Joint partner in conducting the biennial SSP Health Survey.
• Washington State Department of HealthcoreStrategic or Co-development PartnerState agency partner providing funding support and collaboration on drug user health initiatives, syringe services programs, and opioid response efforts.
• Center for Novel Therapeutics in Addiction Psychiatry (NTAP)coreStrategic or Co-development PartnerNTAP joined ADAI in February 2026, expanding the institute's research into psychedelic compounds and evidence-based behavioral interventions for addiction treatment.
• Fetal Alcohol & Drug Unit (FADU)coreStrategic or Co-development PartnerFADU is housed within ADAI and focuses on fetal alcohol spectrum disorders, operating the award-winning Parent-Child Assistance Program for mothers with substance use issues.
• Hepatitis Education ProjectmajorStrategic or Co-development PartnerPartner in the WA Community Drug Checking Network providing drug checking services in Seattle.
• Blue Mountain Heart to HeartmajorStrategic or Co-development PartnerDrug checking site partner serving Walla Walla, Kennewick, and Clarkston communities.
• Sound PathwaysmajorStrategic or Co-development PartnerDrug checking site partner serving Everett, WA.
• Tacoma Needle ExchangemajorStrategic or Co-development PartnerDrug checking site partner serving Tacoma, WA.
• Whatcom County Health and Community ServicesmajorStrategic or Co-development PartnerDrug checking site partner serving Bellingham, WA.
• SHARE (Vancouver, WA)majorStrategic or Co-development PartnerDrug checking site partner serving Vancouver, WA.
• Frontier Behavioral Health (FBH)majorStrategic or Co-development PartnerADAI's Caleb Banta-Green's work on integrated behavioral health was modeled for a new center in Spokane spearheaded by FBH and CHAS Health, with Senator Cantwell securing $2M HRSA funding.
• Community Health Association of Spokane (CHAS Health)majorStrategic or Co-development PartnerPartner in developing an integrated behavioral health center modeled after ADAI's Caleb Banta-Green's work.

Scale indicators5 records

Recent moves7 records

Expansion highlights6 records

Broad incumbents

• McLean Hospital — Alcohol and Drug Abuse Research Program: Harvard-affiliated psychiatric hospital with a dedicated addiction neuroscience research program — comparable as an academic medical center hub conducting addiction research and clinical trials.
• National Institute on Drug Abuse (NIDA) Intramural Research Program: Federal agency that funds much of ADAI's work and runs its own intramural addiction research — a funder-and-peer combination that defines the field ADAI operates in.
• Hazelden Betty Ford Foundation: Largest US private nonprofit addiction treatment provider with a research arm (Butler Center for Research) that conducts addiction science, workforce training, and publishes implementation research — overlapping ADAI's combination of research, training, and treatment services.

Direct peers

• Pacific Institute for Research and Evaluation (PIRE): Nonprofit research organization with multiple centers studying alcohol, drug, and injury prevention — comparable in scope to ADAI's multi-center research model and federal funding mix.
• Center on Addiction (formerly CASA Columbia): National nonprofit that conducts addiction research, policy analysis, and public education — a peer on the research-to-policy continuum ADAI occupies in Washington State, with a national footprint.
• Alcohol Research Group (Public Health Institute): Public Health Institute-affiliated research center conducting epidemiological and policy research on alcohol and drug use, comparable as a sister institution in the addiction research ecosystem with national NIH funding.
• Friends Research Institute: Nonprofit research organization conducting clinical trials and behavioral research on substance use disorders, often as part of the NIDA CTN — a direct peer as a CTN-affiliated addiction research institute.
• Recovery Research Institute at Massachusetts General Hospital: Academic addiction research institute embedded in a major hospital system that publishes peer-reviewed studies on recovery, treatment effectiveness, and stigma — directly comparable as a hospital-affiliated addiction research center.
• Chestnut Health Systems — Lighthouse Institute: Nonprofit research and treatment organization that developed the GAIN (Global Appraisal of Individual Needs) instruments and conducts substance use disorder research and implementation science, closely mirroring ADAI's CAAHS/C-TAP work.
• University of Michigan Addiction Center: University-based addiction research and training center at a major public university, structurally analogous to ADAI as an academic hub combining research, training, and treatment research.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xbsky.app/profile/adaiuw.bsky.social
• LinkedInlinkedin.com/company/adai-uw

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Subsidiaries9 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Addictions, Drug & Alcohol Institute (ADAI) at the University of Washington